SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-21-005623
Filing Date
2021-05-13
Accepted
2021-05-13 16:44:58
Documents
41
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnpr10q.htm 10-Q 561642
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit31-1.htm EX-31.1 10502
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit31-2.htm EX-31.2 9963
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit32-1.htm EX-32.1 7838
5 IMAGE pipelinemay2021.jpg GRAPHIC 30476
  Complete submission text file 0001654954-21-005623.txt   2014270

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mono-20210331.xml EX-101.INS 251415
7 XBRL TAXONOMY EXTENSION SCHEMA mono-20210331.xsd EX-101.SCH 16160
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mono-20210331_cal.xml EX-101.CAL 24469
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mono-20210331_def.xml EX-101.DEF 53103
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mono-20210331_lab.xml EX-101.LAB 148751
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mono-20210331_pre.xml EX-101.PRE 117466
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39070 | Film No.: 21920317
SIC: 2834 Pharmaceutical Preparations